Medical Innovation in the Changing Healthcare Marketplace: Conference Summary (2002)
Chapter: Appendix A: Conference Agenda
A
Conference Agenda
The National Academies
Board on Science, Technology, and Economic Policy
Board on Health Care Services, Institute of Medicine
Agenda
Conference on Medical Innovation in the Changing Healthcare Marketplace
June 14-15, 2001
National Academies Main Building
2100 C Street, NW, Washington, DC
June 14
|
8:00 AM |
Continental Breakfast |
|
8:30 AM |
Welcome and Introduction of Keynote Speaker Cochair: Ed Penhoet, UC Berkeley |
|
8:35 AM |
Keynote Address—Encouraging High-Value Innovation: Medicare and Other Federal Policies |
|
Speaker: |
Mark McClellan, Council of Economic Advisers |
|
9:15 AM |
Objectives for the Conference Cochairs: Ed Penhoet, UC Berkeley, and Kathy Behrens, RS Investments |
The cochairs will outline the background to and their goals for the conference.
|
9:45 AM |
Report from an NAE Workshop on Engineering and Health Care Delivery Systems |
|
Speaker: |
Jerry Grossman, Kennedy School of Government, Harvard University |
|
10:00 AM |
Panel I: The Macro Picture—Trends in Health Care Costs and Benefits |
This session will examine at the macro level the extent to which new medical technology is driving up health care costs and, the equally important issue of whether new medical technology is bringing more benefits.
|
Moderator: |
Philip Aspden, NRC |
|
Panelists: |
|
|
|
• Sheila Smith, CMS, formerly HCFA • Alison Keith, Pfizer, Inc. (ret.) • Kevin Murphy, University of Chicago |
|
11:15 AM |
Break. |
|
11:30 AM |
Panel IIA: Cardiovascular Disease—Trends in Health Care Costs and Benefits |
In this session the panelists will examine in more detail trends in the costs and benefits of new medical technology by considering cardiovascular disease. The long-term health care cost implications of successful treatment of cardiovascular disease will be considered.
|
Moderator: |
David Gollaher, California Healthcare Institute |
|
Panelists: |
|
|
|
• Elizabeth Nabel, NHLBI • Dan Mark, Duke University • Paul Citron, Medtronic • David Cutler, Harvard University |
|
1:00 PM |
Lunch |
|
2:00 PM |
Panel IIB: Cardiovascular Disease—Fostering High-Value Medical Innovation |
Panelists will examine the barriers to innovation in the development, adoption, and diffusion of new treatments of cardiovascular disease. Ways to overcome identified barriers will also be considered.
|
Moderator: |
Kathy Behrens, RS Investments |
|
Panelists: |
|
|
|
• Tom Fogarty, Stanford University • Mark Hlatky, Stanford University • Laurel Sweeney, Philips Medical Systems |
|
3:30 PM |
Break. |
|
3:45 PM |
Panel IIIA: Metastatic Melanoma—Trends in Health Care Costs and Benefits |
In this session the panelists will examine in more detail trends in the costs and benefits of new medical technology by considering metastatic melanoma. The long-term health care cost implications of successful treatment of metastatic melanoma will be considered.
|
Moderator: |
Gil Omenn, University of Michigan |
|
Panelists: |
|
|
|
• Steven Rosenberg, National Cancer Institute • Mike Atkins, Beth Israel Deaconess Medical Center, Harvard Medical School • Margaret Tucker, National Cancer Institute • Bruce Hillner, Medical College of Virginia |
|
5:30 PM |
Close |
|
6:00 PM |
Reception |
* * * *
June 15
|
8:00 AM |
Continental Breakfast. |
|
8:30 AM |
Welcome and Recap Cochairs: Ed Penhoet, UC Berkeley, and Kathy Behrens, RS Investments |
|
8:45 AM |
Key Note Speaker |
|
Speaker: |
David Lawrence, Kaiser Permanente |
Dr. Lawrence will speak about the recent IOM report, Crossing the Quality Chasm, medical care in the 21st century, the drivers of innovation, and possible public policy levers to foster high-value medical innovation.
|
9:45 AM |
Panel IIIB: Metastatic Melanoma—Fostering High-Value Medical Innovation |
Panelists will examine the barriers to innovation in the development, adoption, and diffusion of new treatments of metastatic melanoma. Ways to overcome identified barriers will also be considered.
|
Moderator: |
Ed Penhoet, UC Berkeley |
|
Panelists: |
|
|
|
• Bruce Scharschmidt, Chiron • Richard Pazdur, FDA • Robert Young, Fox Chase Cancer Center • Jonathan Lewis, Antigenics |
|
11:00 AM |
Break. |
|
11:15 AM |
Panel IV: The Macro Picture—Fostering High-Value Medical Innovation |
In this session panelists will examine public policy initiatives at the macro level that will foster the development, adoption, and diffusion of high-value medical innovation.
|
Moderator: |
Alan Garber, Stanford University |
|
Panelists: |
|
|
|
• Susan Bartlett Foote, University of Minnesota • Sean Tunis, CMS, formerly HCFA • Jamie Robinson, UC Berkeley |
|
1:00 PM |
Lunch |
|
1:30 PM |
Panel IV (cont.): The Macro Picture—Fostering High-Value Medical Innovation |
|
Panelists: |
|
|
|
• Brandon Hull, Cardinal Partners • Fran Visco, National Breast Cancer Coalition • John Ford, House Committee on Energy and Commerce/ Democratic Staff |
|
2:45 PM |
Session VI: Wrap-up Discussion |
The final session will allow participants to discuss the key issues arising from the conference.
|
Moderators: |
Cochairs: Ed Penhoet, UC Berkeley, Kathy Behrens, RS Investments. |
